SE463209B - 5-amino-2-/3-(3-piperidinometylfenoxi)propylamino/-4 (3h)-pyrimidon, saett att framstaella denna och en farmaceutisk beredning - Google Patents

5-amino-2-/3-(3-piperidinometylfenoxi)propylamino/-4 (3h)-pyrimidon, saett att framstaella denna och en farmaceutisk beredning

Info

Publication number
SE463209B
SE463209B SE8404729A SE8404729A SE463209B SE 463209 B SE463209 B SE 463209B SE 8404729 A SE8404729 A SE 8404729A SE 8404729 A SE8404729 A SE 8404729A SE 463209 B SE463209 B SE 463209B
Authority
SE
Sweden
Prior art keywords
compound
piperidinomethylphenoxy
amino
propylamino
acid
Prior art date
Application number
SE8404729A
Other languages
English (en)
Swedish (sv)
Other versions
SE8404729L (sv
SE8404729D0 (sv
Inventor
A A Algieri
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SE8404729D0 publication Critical patent/SE8404729D0/xx
Publication of SE8404729L publication Critical patent/SE8404729L/xx
Publication of SE463209B publication Critical patent/SE463209B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE8404729A 1983-09-21 1984-09-20 5-amino-2-/3-(3-piperidinometylfenoxi)propylamino/-4 (3h)-pyrimidon, saett att framstaella denna och en farmaceutisk beredning SE463209B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/534,426 US4772704A (en) 1983-09-21 1983-09-21 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity

Publications (3)

Publication Number Publication Date
SE8404729D0 SE8404729D0 (sv) 1984-09-20
SE8404729L SE8404729L (sv) 1985-03-22
SE463209B true SE463209B (sv) 1990-10-22

Family

ID=24129972

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404729A SE463209B (sv) 1983-09-21 1984-09-20 5-amino-2-/3-(3-piperidinometylfenoxi)propylamino/-4 (3h)-pyrimidon, saett att framstaella denna och en farmaceutisk beredning

Country Status (36)

Country Link
US (1) US4772704A (xx)
JP (1) JPH0643310B2 (xx)
KR (1) KR900001198B1 (xx)
AR (2) AR242385A1 (xx)
AT (1) AT387965B (xx)
AU (1) AU583479B2 (xx)
BE (1) BE900652A (xx)
CA (1) CA1260463A (xx)
CH (1) CH665840A5 (xx)
CS (1) CS249147B2 (xx)
CY (1) CY1561A (xx)
DD (1) DD226881A5 (xx)
DE (1) DE3434578A1 (xx)
DK (1) DK162987C (xx)
ES (4) ES8607253A1 (xx)
FI (1) FI83868C (xx)
FR (1) FR2552082B1 (xx)
GB (1) GB2146994B (xx)
GR (1) GR80439B (xx)
HK (1) HK73790A (xx)
HU (1) HU193227B (xx)
IE (1) IE58083B1 (xx)
IL (1) IL72990A (xx)
IT (1) IT1176739B (xx)
LU (1) LU85550A1 (xx)
NL (1) NL8402898A (xx)
NO (1) NO161561C (xx)
NZ (1) NZ209572A (xx)
OA (1) OA07820A (xx)
PT (1) PT79256B (xx)
SE (1) SE463209B (xx)
SG (1) SG60890G (xx)
YU (1) YU45205B (xx)
ZA (1) ZA847345B (xx)
ZM (1) ZM4984A1 (xx)
ZW (1) ZW16084A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2873340B2 (ja) * 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質ｔａｎ―１０５７，その製造法および用途
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (xx) * 1978-02-13 1983-03-05 Smith Kline French Lab
ES477520A1 (es) * 1978-02-25 1979-06-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevas penicilinas.
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
CA1140129A (en) * 1979-08-21 1983-01-25 Ronald J. King 4-pyrimidone derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4468399A (en) * 1981-12-28 1984-08-28 Eli Lilly And Company 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives

Also Published As

Publication number Publication date
DD226881A5 (de) 1985-09-04
AU583479B2 (en) 1989-05-04
AT387965B (de) 1989-04-10
GB2146994B (en) 1987-09-03
FR2552082B1 (fr) 1987-02-20
IT8422744A1 (it) 1986-03-20
DK162987B (da) 1992-01-06
IE58083B1 (en) 1993-06-30
OA07820A (fr) 1986-11-20
LU85550A1 (fr) 1985-06-04
FI843643L (fi) 1985-03-22
SG60890G (en) 1990-09-07
FI843643A0 (fi) 1984-09-18
HUT35259A (en) 1985-06-28
ATA300984A (de) 1988-09-15
NO161561C (no) 1989-08-30
YU161384A (en) 1987-12-31
KR900001198B1 (ko) 1990-02-28
NL8402898A (nl) 1985-04-16
FI83868B (fi) 1991-05-31
ES8704465A1 (es) 1987-04-01
DE3434578A1 (de) 1985-04-11
IT1176739B (it) 1987-08-18
NO843726L (no) 1985-03-22
DK162987C (da) 1992-06-01
ES544213A0 (es) 1987-04-01
AU3335184A (en) 1985-03-28
GB2146994A (en) 1985-05-01
ES8704155A1 (es) 1987-03-16
DK450484D0 (da) 1984-09-20
DK450484A (da) 1985-03-22
AR242789A1 (es) 1993-05-31
NO161561B (no) 1989-05-22
US4772704A (en) 1988-09-20
IE842406L (en) 1985-03-21
ZM4984A1 (en) 1985-05-21
AR242385A1 (es) 1993-03-31
ES8607253A1 (es) 1986-05-16
ZA847345B (en) 1985-06-26
NZ209572A (en) 1988-05-30
ES536054A0 (es) 1986-05-16
CY1561A (en) 1991-03-22
GR80439B (en) 1985-01-22
YU45205B (en) 1992-05-28
CH665840A5 (de) 1988-06-15
SE8404729L (sv) 1985-03-22
FI83868C (fi) 1991-09-10
IT8422744A0 (it) 1984-09-20
ES551500A0 (es) 1987-03-16
CS249147B2 (en) 1987-03-12
FR2552082A1 (fr) 1985-03-22
JPS6087271A (ja) 1985-05-16
HK73790A (en) 1990-09-28
GB8423863D0 (en) 1984-10-24
KR850002259A (ko) 1985-05-10
BE900652A (fr) 1985-03-21
ES8702897A1 (es) 1987-01-16
PT79256A (en) 1984-10-01
PT79256B (en) 1986-11-20
JPH0643310B2 (ja) 1994-06-08
ZW16084A1 (en) 1985-01-16
CA1260463A (en) 1989-09-26
ES551501A0 (es) 1987-01-16
SE8404729D0 (sv) 1984-09-20
HU193227B (en) 1987-08-28
IL72990A (en) 1990-07-12

Similar Documents

Publication Publication Date Title
US4390701A (en) 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
DD207913A5 (de) Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DK2932968T3 (en) CONNECTION TO TREATMENT OF ALFA-ADRENERG MEDIED CONDITIONS
US4522943A (en) Chemical compounds
SE463209B (sv) 5-amino-2-/3-(3-piperidinometylfenoxi)propylamino/-4 (3h)-pyrimidon, saett att framstaella denna och en farmaceutisk beredning
US4395553A (en) Chemical compounds
US4526973A (en) Chemical compounds
US4503051A (en) Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use
DE69107874T2 (de) Imidazolderivate und diese Imidazolderivate als Wirkstoffe enthaltende Antiepileptika.
US4539316A (en) Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
US4546188A (en) Substituted 1,2-diaminocyclobutene-3,4-diones
US4607105A (en) 3-cyclobutene-1,2-dione intermediates
JPH0262554B2 (xx)
US4788184A (en) Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents
EP0150073A1 (en) 3,4-Disubstituted-1,2,5-oxadiazoles having histamine H2-receptor antagonist activity
DE3850304T2 (de) 3-Arylcarbamoyl-5-aminomethyl-oxazolidine sowie deren Salz mit pharmakologisch verträglichen Säuren.
CS249150B2 (cs) Způsob výroby 2,5-disubstituovaných 4 (3H)-pyrimidonů
DE3514351A1 (de) Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS6051176A (ja) 新規イミダゾリン誘導体及びその製法
GB2147899A (en) Chemical intermediates derived from cyclobutene
NO173235B (no) Analogifremgangsmaate til fremstilling av 4(3h)pyrimidoner

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404729-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8404729-9

Format of ref document f/p: F